I used to talk about celiac disease and gluten sensitivity as if one were a louder version of the other. Then our daughter Kolbie received a celiac diagnosis, and I wanted to understand why one person can eat a slice of sourdough and feel fine while another needs an intestinal biopsy. I am not a clinician, and this post is general education, not medical guidance. I am a mom who reads primary research. I started with old medical journals, not wellness summaries. What I found changed how I read every label in our pantry.

Celiac Disease: From Bedside Observation to Biopsy

The first clear clinical account of celiac disease appears in an 1888 lecture by Samuel Gee, a physician at St Bartholomew's Hospital in London. Gee described children and adults with pale, loose stools, a swollen belly, and failure to thrive. He told his colleagues the disease could be treated by diet, but he could not name the food. His lecture, "On the Coeliac Affection," is still cited in textbooks.

The breakthrough came from a war zone. During the Dutch famine of 1944 and 1945, wheat and bread vanished from the Netherlands. Willem-Karel Dicke, a pediatrician in The Hague, noticed that children with celiac symptoms improved while wheat was scarce. When relief supplies brought bread back, their symptoms returned. He published these observations in 1950. By the mid-1950s, small-intestine biopsy techniques allowed doctors to see the flattened villi that define celiac disease. Doctors could finally see a visible signature.

The Blood Tests That Split the Diagnoses

By the 1980s, researchers introduced blood tests that changed the path to diagnosis. Anti-endomysial antibody testing arrived in that decade. Anti-tissue transglutaminase IgA testing became widely used in the late 1990s after researchers identified tissue transglutaminase as the main autoantigen in celiac disease. A celiac workup became more than a clinical guess.

Researchers added genetic testing as another layer. Almost all people with celiac disease carry the HLA-DQ2 or HLA-DQ8 gene variants. Many people without celiac disease carry one of those variants too. That means the genetic test rules things out more than it rules things in. The diagnosis still rests on a combination of serology, biopsy, and a response to a gluten-free diet.

A 2012 study by Rubio-Tapia and colleagues estimated that about 1 in 141 Americans have celiac disease. Global estimates from several countries cluster near 1 percent. That makes it common enough to matter, but rare enough that many people with gut symptoms do not have it.

Gluten Sensitivity Arrives in 2011

While celiac disease gained a clearer definition, a different group of people stayed in limbo. They described bloating, brain fog, fatigue, or gut symptoms after eating wheat. Their celiac blood tests came back normal. Their biopsies were normal. Wheat allergy tests were negative. They did not fit the celiac box, but they described something real.

A 2011 study from Monash University in Australia gave this group a scientific foothold. Jessica Biesiekierski and her colleagues recruited people without celiac disease who had irritable-bowel symptoms and felt better off gluten, then gave participants gluten or a placebo baked into bread and muffins in a double-blind placebo-controlled trial. Gluten triggered more symptoms than the placebo. The paper helped bring the term non-celiac gluten sensitivity into research use.

Then the picture got messier. A 2013 follow-up by the same group found that when participants followed a diet low in FODMAPs, the specific effect of gluten shrank. FODMAPs are fermentable carbohydrates found in wheat and many other foods. Some participants reacted to fructans, a type of FODMAP in wheat, more than to gluten. That distinction changes what to remove and what to reintroduce.

In 2015, an international group led by Alessio Fasano and Carlo Catassi published the Salerno experts' criteria for diagnosing non-celiac gluten sensitivity. The protocol requires ruling out celiac disease and wheat allergy first, then a double-blind placebo-controlled gluten challenge. That process is time-consuming. Many clinics do not use it in full. Diagnosis often remains a careful exclusion rather than a positive test.

Why the Distinction Matters in a Shared Kitchen

In our house, the distinction is not academic. Celiac disease means a gluten-containing crumb can trigger an autoimmune reaction in the small intestine. The damage can be invisible at first and accumulates over time. Non-celiac gluten sensitivity produces symptoms without the same intestinal damage. Both are real. The label-reading instructions differ.

Gluten appears in obvious places like bread and pasta. It also shows up in products that families do not expect: bouillon cubes, seasoning packets, soy sauce, certain spice blends, and some flavored chips. For a celiac household, cross-contact in a shared kitchen means dedicated cutting boards, separate condiment containers, and a close read of every label. For a gluten-sensitive household, the conversation often focuses more on symptom tracking and reintroduction than on avoiding a speck of flour.

This is where Clean Monday Meals fits our routine. Our seasonings are 100% gluten-free, dairy-free, and soy-free, and the ingredient lists are short enough to read out loud. When Kolbie cooks for herself or for friends, I do not have to hover over every packet.

Wheat allergy is a third category worth naming. It is an IgE-mediated allergic response that can cause hives, swelling, or breathing difficulty soon after eating wheat. It is different from celiac disease and from non-celiac gluten sensitivity, and it requires its own testing. The three conditions that involve wheat and gluten reactions are:

• Celiac disease: an autoimmune response to gluten that damages the small intestine
• Wheat allergy: an IgE-mediated allergic reaction to wheat proteins
• Non-celiac gluten sensitivity: symptoms after gluten or wheat exposure without celiac disease or wheat allergy

What the Research Still Has Not Settled

In the next decade, researchers will work to separate gluten from fructans and to map the gut microbiome signatures of people who react to each. Some research groups are testing enzymes that break down gluten in the stomach to learn whether they reduce reactions in non-celiac gluten sensitivity. Others are examining intestinal permeability and immune markers in search of a first biomarker for gluten sensitivity. None of this is settled.

I also see a cultural shift. A gluten-free label once meant a medical necessity. It now also signals a preference or a wellness choice. That shift created a market and a lot of noise. The historical record helped me separate the two. Celiac disease has more than a century of documentation. Non-celiac gluten sensitivity has less than two decades of formal study. Some researchers expect it to split into subtypes as the science matures.

The most useful thing I learned is to ask about testing before removing gluten. Celiac blood tests and a biopsy work best when gluten is still in the diet. Talk to your clinician about the sequence.

The next time someone uses the terms interchangeably, I now know why the distinction took so long to emerge. Researchers developed the tools for celiac disease first. Celiac disease got its biopsy and its blood test first. Gluten sensitivity is still waiting for its biomarker.

This post is general education, not medical guidance. If this helped you, share it with a friend who is in the same diagnostic fog. For more support, our free Recipe App has hundreds of gluten-free, dairy-free family recipes, and the community forum is a place to ask questions as you sort through labels. Tag us @cleanmondaymeals if you make something.